GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » Peter Lynch Fair Value
中文

Ultralife (Ultralife) Peter Lynch Fair Value : N/A (As of Apr. 24, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Ultralife Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Ultralife's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Ultralife was 1.28. The lowest was 1.28. And the median was 1.28.


ULBI's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Industrial Products industry.
Industry Median: 1.29
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Ultralife Peter Lynch Fair Value Historical Data

The historical data trend for Ultralife's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultralife Peter Lynch Fair Value Chart

Ultralife Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.06 - - -

Ultralife Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ultralife's Peter Lynch Fair Value

For the Electrical Equipment & Parts subindustry, Ultralife's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultralife's Price-to-Peter-Lynch-Fair-Value Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Ultralife's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Ultralife's Price-to-Peter-Lynch-Fair-Value falls into.



Ultralife Peter Lynch Fair Value Calculation

Ultralife's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0.55
=N/A

Ultralife's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.55.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Ultralife  (NAS:ULBI) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Ultralife's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=8.73/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Ultralife's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultralife (Ultralife) Business Description

Traded in Other Exchanges
Address
2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from Battery and Energy Products segment.
Executives
Bradford T Whitmore 10 percent owner 5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Michael Edward Manna director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
W. Shaw Robert director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Janie Goddard director C/O ACON - 1133 CONNECTICUT AVENUE, NW, SUITE 700, WASHINGTON DC 20036
Thomas Louis Saeli director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Philip A Fain officer: Vice President C/O CXO ON THE GO OF DELAWARE, LLC, 3349 MONROE AVENUE, # 256, ROCHESTER NY 14618
Michael D Popielec director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Steven Mark Anderson director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Sunray I, Llc 10 percent owner 1560 SHERMAN AVENUE, SUITE 900, EVANSTON IL 60201
James A. Croce director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Spurgeon Corp 10 percent owner 407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
Patricia C Barron director 6601 WEST BROAD STREET, P O BOX 27003, RICHMOND VA 23261-7003
Daniel W Christman director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Paula H Cholmondeley director 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ranjit C Singh director